cefotetan has been researched along with Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, S; Ikeda, A; Kuroda, K; Motoi, I; Ohkawa, M; Okasho, A; Sawaki, M; Shimamura, M; Shoda, R; Sugata, T; Tokunaga, S | 1 |
| Hegarty, T; Wise, R; Wright, N | 1 |
| Jin, BW; Saito, H; Sato, K | 1 |
| Albanese, J; Martin, C; Thomachot, L | 1 |
| Richards, DM; Ward, A | 1 |
2 review(s) available for cefotetan and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of cefotetan.
Topics: Absorption; Biological Availability; Cefotetan; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Diseases; Metabolic Clearance Rate; Protein Binding; Tissue Distribution | 1994 |
Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Bacteria; Bacterial Infections; Cefotetan; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Kidney Diseases; Kinetics; Respiratory Tract Infections; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1985 |
1 trial(s) available for cefotetan and Kidney Diseases
| Article | Year |
|---|---|
Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Bacteria; Bacterial Infections; Cefotetan; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Kidney Diseases; Kinetics; Respiratory Tract Infections; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1985 |
3 other study(ies) available for cefotetan and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
Topics: Adult; Aged; Cefotetan; Cephalosporins; Cephamycins; Creatinine; Half-Life; Humans; Kidney; Kidney Diseases; Kinetics; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 1983 |
Cefotetan elimination in patients with varying degrees of renal dysfunction.
Topics: Anti-Bacterial Agents; Cefotetan; Cephalosporins; Cephamycins; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Kinetics; Male; Middle Aged | 1983 |
Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.
Topics: Animals; Cefotetan; Cefoxitin; Cephamycins; Female; Kidney Diseases; Mice; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous | 1984 |